By Tracy Qu
Shares of ClouDr Group rose sharply in Hong Kong after the Chinese medical software provider said it will integrate AI firm DeepSeek's model into its core product.
The stock rose 12% to HK$1.81 in Thursday morning trade, extending year-to-date gains to 52.5% and outperforming the benchmark Hang Seng Index, which was up 0.1%.
The company, which provides digital solutions for managing chronic conditions, said it has integrated the DeepSeek-R1 model with its medical artificial-intelligence system ClouDr Brain to improve data analysis. This is expected to help hospitals and pharmacies enhance the use of ClouDr's AI system to manage patients with chronic medical conditions, it said.
"The integration of the DeepSeek-R1 model in ClouDr Brain combines advanced data analysis and AI technology to provide precise decision-making support for chronic disease management through big data analysis and machine learning algorithms," the company said.
Founded in 2014, ClouDr specializes in healthcare digitalization.
DeepSeek's R1 large-language model made waves when it was released in January for purportedly achieving high efficiency with lower-tech chips at cheaper costs. OpenAI CEO Sam Altman has called it "an impressive model."
Write to Tracy Qu at tracy.qu@wsj.com
(END) Dow Jones Newswires
February 05, 2025 22:15 ET (03:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。